Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu® ) among adults in THIN database of electronic UK primary healthcare records-Reference-Cited by-同舟云学术

Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu® ) among adults in THIN database of electronic UK primary healthcare records

Published:2017-11-20 Issue:1 Volume:27 Page:52-58
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Hall Gillian C.¹^ORCID,Davies Paul T.G.²,Karim M. Yousuf³,Haag Mendel D.M.⁴,O'Leary Caroline⁵

Affiliation:

1. Grimsdyke House; London UK

2. Northampton General Hospital NHS Trust; Northampton UK

3. Frimley Park, Royal Surrey County; St Peter's Hospitals; Surrey UK

4. Seqirus; Amsterdam The Netherlands

5. QuinitilesIMS Ltd; London UK

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference42 articles.

1. Influenza-associated morbidity and mortality in young and middle-aged women;Neuzil;JAMA,1999

2. New estimates of influenza-related pneumonia and influenza hospitalizations among the elderly;McBean;Int J Infect Dis,2004

3. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database;Mangtani;J Infect Dis,2004

4. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland;Mutsch;N Engl J Med,2004

5. Guillain-Barre syndrome after influenza vaccination in adults: a population-based study;Juurlink;Arch Intern Med,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccines and Bell's palsy: A narrative review;Therapies;2022-08

2. The Use of Electronic Health Records to Study Drug-Induced Hypersensitivity Reactions from 2000 to 2021;Immunology and Allergy Clinics of North America;2022-05

3. Systematic review of the efficacy, effectiveness and safety of cell‐based seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age;Reviews in Medical Virology;2022-02-08